Cargando…
PET Imaging as a Tool for Assessing COVID-19 Brain Changes
A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography...
Autores principales: | Fontana, Igor C., Bongarzone, Salvatore, Gee, Antony, Souza, Diogo O., Zimmer, Eduardo R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580682/ https://www.ncbi.nlm.nih.gov/pubmed/33131922 http://dx.doi.org/10.1016/j.tins.2020.10.010 |
Ejemplares similares
-
A Medicinal
Chemistry Perspective on Excitatory Amino
Acid Transporter 2 Dysfunction in Neurodegenerative Diseases
por: Fontana, Igor C., et al.
Publicado: (2023) -
Correction
to “A Medicinal Chemistry Perspective
on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative
Diseases”
por: Fontana, Igor C., et al.
Publicado: (2023) -
Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging
por: Singh, Nisha, et al.
Publicado: (2018) -
About the source and consequences of (18)F-FDG brain PET hypometabolism in short and long COVID-19
por: Fontana, Igor C., et al.
Publicado: (2021) -
Electrochemical [(11)C]CO(2) to [(11)C]CO conversion for PET imaging
por: Anders, David A., et al.
Publicado: (2017)